Evans and Partners have increased their current fair valuation, to 44c. They have a 45% chance of success for PYC-001 now and included the priority review voucher in the calculations at the same risk.( So in 2030 45m out of US $100m which is still conservative considering the recent sale at $158m). They still have a 50m cap raise with dilution factored in but note that a deal would remove that and therefore add considerable value at the time of annct.
- Forums
- ASX - By Stock
- A clue to a deal
PYC
pyc therapeutics limited
Add to My Watchlist
0.79%
!
$1.28

Evans and Partners have increased their current fair valuation,...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.28 |
Change
0.010(0.79%) |
Mkt cap ! $743.6M |
Open | High | Low | Value | Volume |
$1.27 | $1.28 | $1.27 | $195.2K | 153.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 13993 | $1.27 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.28 | 63167 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 13993 | 1.265 |
1 | 15000 | 1.260 |
2 | 12414 | 1.255 |
2 | 3000 | 1.250 |
1 | 414 | 1.245 |
Price($) | Vol. | No. |
---|---|---|
1.275 | 63167 | 3 |
1.280 | 15209 | 4 |
1.285 | 2739 | 2 |
1.290 | 25161 | 2 |
1.295 | 24914 | 2 |
Last trade - 13.40pm 27/06/2025 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online